On Feb. 15, Leslie Moonves, the brilliant CEO of CBS, gave a piece of good news to investors — there would be an addition to the bottom line in 2012 of about $190 million, thanks to huge spending on political commercials coming into the network and its owned and operated...

US/EU companies that protect their drug brands in turn protect our lives. We need other countries to do more and we need to help them in doing so.

It has become a ritual in Washington to "restart" military exchanges with China. Regular contact has been suspended a number of times over the past two decades and each new cancellation sparks a round of worrying over the causes of the rift.

The same money can't be spent twice. ObamaCare tries to do precisely that, and the government will have to borrow the difference.

Myriad responses are required for all parts of the substandard drug problem.

This paper explores the opportunities presented by the Trans-Pacific Partnership (TPP) to Japan to revitalize its trade policy, bolster economic growth, and increase participation in regional multilateral fora for the 21st century. Despite its strengths, Japan has continued to face problems caused by its economic, political,...

Medicines have to pass through a rigorous series of clinical trials to prove their efficacy and safety; by bypassing systems that are in place, the manufacturers of counterfeit medicines are not only illegally profiting from others' endeavors--they are also putting patients' lives at risk.

Baghdad is all atwitter over the P-5+1 talks with Iran beginning today. A sandstorm kept many European and Western diplomats from landing, but the Iranians were out in full force, with Iranian negotiator Saeed Jalili leading the way.